Abstract:<p>Several advances in nanomedicine have been accompanied by rising concerns about the bioaccumulation and toxicity of gold nanoparticles (AuNPs). Here, we assessed the <em>in vivo</em> fate of diversely sized AuNPs that were injected into mice as a computed tomography contrast agent and examined with multi-scale analyses across the organ, tissue, cell, and subcellular levels. After focusing on the strong detected accumulation in livers, our data revealed a set of three clear, exposure-time-dependent patterns based on i) AuNPs deposit morphology and ii) readily identifiable phenotypes for AuNP-impacted subcellular vesicles. Importantly, we detected no obvious differences in liver function, liver cell apoptosis, or autophagy upon exposure to AuNPs. Thus, our study illustrates an accessible experimental and high-resolution data interpretation framework for quickly obtaining and contextualizing informative trends about any AuNP-triggered patterns of subcellular damage in nanomedicine studies; these can help guide cytotoxity and safety testing of diagnostic nanomedical technologies.</p>

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are to evaluate the biodistribution and accumulation of gold nanoparticles (AuNPs) in vivo and their effects on the sub - structures of liver cells, especially the changes under different exposure times. Specifically, the study focuses on the following aspects: 1. **Fate and distribution in vivo**: Evaluate the distribution of AuNPs of different sizes in mice, especially their accumulation in the liver. 2. **Changes at the sub - cellular level**: Through multi - scale analysis (from the organ to the cell and sub - cellular levels), study the deposition morphology of AuNPs in the liver and their destructive effects on sub - cellular vesicles, and observe the development patterns of these changes over time. 3. **Safety assessment**: Detect whether AuNPs will have a significant impact on liver function, hepatocyte apoptosis or autophagy, so as to evaluate their potential cytotoxicity and safety. ### Research background In recent years, significant progress has been made in the field of nanomedicine, but at the same time, concerns about the bioaccumulation and toxicity of gold nanoparticles have also been raised. In order to better understand the safety and potential risks of AuNPs, this study uses a variety of technical means (such as CT imaging, ICP - OES analysis, transmission electron microscopy, etc.) to discuss in detail the behavior of AuNPs in mice and their effects on liver cells. ### Main findings 1. **Time - dependent pattern**: - **Deposition stage (Stage I)**: On the 1st day after injection, AuNPs are mainly deposited in approximately spherical vesicles, and AuNP aggregates are also spherical. - **Deformation stage (Stage II)**: On the 6th day after injection, the morphology of AuNP aggregates becomes irregular, part of the vesicle membranes are broken, and AuNPs tend to aggregate near the vesicle membranes. - **Aggregation stage (Stage III)**: On the 30th day after injection, AuNPs form large clusters with a diameter of about 2,000 nm, the vesicles are completely destroyed, and AuNP deposits form dense large clusters without obvious peripheral membranes. 2. **Safety assessment**: - Liver function indicators (ALT and AST) are within the normal range on the 1st, 6th and 30th days after injection, indicating that AuNPs have no obvious impact on basic liver function. - No obvious apoptosis phenomenon was found by TUNEL detection. - There is no obvious change in the expression of autophagy - related protein LC3B, indicating that AuNPs do not significantly affect the autophagy process. ### Conclusion This study provides a comprehensive experimental framework for quickly obtaining and interpreting the sub - cellular damage patterns caused by AuNPs, which is helpful for guiding the cytotoxicity and safety testing of nanomedicine diagnostic techniques. The research results show that at the dose used, AuNPs have no obvious adverse effects on the function and structure of the mouse liver, but further research is still needed to comprehensively evaluate its long - term safety and potential risks.

Exposure-time-dependent subcellular staging of gold nanoparticles deposition and vesicle destruction in mice livers

Quantitative Imaging Of Gd Nanoparticles In Mice Using Benchtop Cone-Beam X-Ray Fluorescence Computed Tomography System

Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice

The enhancement effect of gold nanoparticles in drug delivery and as biomarkers of drug-resistant cancer cells.

Long-Term Accumulation, Biological Effects and Toxicity of BSA-Coated Gold Nanoparticles in the Mouse Liver, Spleen, and Kidneys

Size-dependent in Vivo Toxicity of PEG-coated Gold Nanoparticles

Size- and surface chemistry-dependent pharmacokinetics and tumor accumulation of engineered gold nanoparticles after intravenous administration.

In Vivo Toxicology of Metabolizable Atomically Precise Au25 Clusters at Ultrahigh Doses

Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy.

Visualizing the intracellular aggregation behavior of gold nanoclusters via structured illumination microscopy and scanning transmission electron microscopy

Storage of Gold Nanoclusters in Muscle Leads to their Biphasic in Vivo Clearance

Selective Metabolic Effects of Gold Nanorods on Normal and Cancer Cells and Their Application in Anticancer Drug Screening.

Non-invasive visualization of tumors in the mouse liver using a novel nanoparticle contrast enhanced micro-CT imaging procedure

Toxicity of gold nanoparticles complicated by the co-existence multiscale plastics

Visualizing Dynamics of Sub-Hepatic Distribution of Nanoparticles Using Intravital Multiphoton Fluorescence Microscopy

Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles.

The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies

Investigating the fate and toxicity of green synthesized gold nanoparticles in albino mice

Intracellular Exposure Dose-Associated Susceptibility of Steatotic Hepatocytes to Metallic Nanoparticles

In Vivo Renal Clearance, Biodistribution, Toxicity of Gold nanoclusters

Silver Nanoparticles Induced Oxidative and Endoplasmic Reticulum Stresses in Mouse Tissues: Implications for the Development of Acute Toxicity after Intravenous Administration.